BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 11, 2006
View Archived Issues
ImClone Hurt By Plans To Remain Independent Entity
ImClone Systems Inc. watched its shares drop Thursday following news that the company is nixing its plans for a merger, partnership or outright sale in favor of continuing on alone. (BioWorld Today)
Read More
FDA Rejection Of Sparlon Trickles Down To Provigil
Read More
Mouse Model May Help Better Quantify Gene Therapy Risks
Read More
After Phase III Hit With Strep Drug, Advancis Planning NDA
Read More
Neurochem Secures Funding Through $60M Credit Facility
Read More
Other News To Note
Read More
Clinic Roundup
Read More